An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery
NCT ID: NCT03604861
Last Updated: 2019-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
534 participants
OBSERVATIONAL
2015-08-31
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The RECOVER study will characterize OUD subjects' recovery process as they transition from the controlled clinical trial environment to the real world setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term
NCT04577144
An Integrated Intervention Involving Recovery Coaching and Cognitive Behavioral Therapy for Opioid Use Disorder
NCT06102200
Initiating Substance Use Disorder Treatment for Hospitalized Opioid Use Disorder Patients.
NCT03212794
Towards Testing the Effectiveness of Recovery Community Centers (RCCs)
NCT07010978
Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment
NCT07197801
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Not applicable - no defined intervention
Participants who received at least one injection of RBP-6000 or placebo and either withdrew from or completed the Phase III clinical program which included studies NCT02357901 (RB-US-13-0001) and NCT02510014 (RB-US-13-0003) were eligible for the RECOVER Study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to comply with study protocol requirements for data collection and provide informed consent.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Indivior Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Study Director, Global Medicines Development
Role: STUDY_CHAIR
Indivior Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Winston Technology Research LLC
Haleyville, Alabama, United States
Boyett Health Services
Hamilton, Alabama, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Behavioral Research Specialists
Glendale, California, United States
Collaborative Neuroscience Networks, Inc.
Long Beach, California, United States
Synergy Research Center
National City, California, United States
North County Clinical Research
Oceanside, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
Amit Vijapura
Jacksonville, Florida, United States
Meridien Research
Lakeland, Florida, United States
Try Research
Maitland, Florida, United States
Innovative Clinical Research
Miami, Florida, United States
Scientific Clinical Research
Miami, Florida, United States
Research Centers of America
Oakland Park, Florida, United States
Louisiana Research Associates
New Orleans, Louisiana, United States
Louisiana Clinical Research
Shreveport, Louisiana, United States
Stanley Street Treatment and Resources
Fall River, Massachusetts, United States
Adams Clinical Trials
Watertown, Massachusetts, United States
Precise Research Centers, Inc.
Flowood, Mississippi, United States
St. Louis Clinical Trials
St Louis, Missouri, United States
Altea Research Institute
Las Vegas, Nevada, United States
Hassman Research Institute
Berlin, New Jersey, United States
Center for Emotional Fitness
Cherry Hill, New Jersey, United States
The Medical Research Network, LLC
New York, New York, United States
Neuro-behavioral Clinical Research
Canton, Ohio, United States
Midwest Clinical Research Center
Dayton, Ohio, United States
Charak Clinical Research Center
Garfield Heights, Ohio, United States
Oklahoma Clinical Research Center
Oklahoma City, Oklahoma, United States
Pahl Pharmaceutical Professionals
Oklahoma City, Oklahoma, United States
CODA
Portland, Oregon, United States
Tipton Medical and Diagnostic Center aka Clinical Research Associates of Central PA
Altoona, Pennsylvania, United States
UPenn Treatment Research Center
Philadelphia, Pennsylvania, United States
Carolina Clinical Trials
Charleston, South Carolina, United States
Pillar Clinic Research, LLC
Dallas, Texas, United States
InSite Clinical Research
DeSoto, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Craft WH, Tegge AN, Keith DR, Shin H, Williams J, Athamneh LN, Stein JS, Chilcoat HD, Le Moigne A, DeVeaugh-Geiss A, Bickel WK. Recovery from opioid use disorder: A 4-year post-clinical trial outcomes study. Drug Alcohol Depend. 2022 May 1;234:109389. doi: 10.1016/j.drugalcdep.2022.109389. Epub 2022 Mar 9.
Ling W, Nadipelli VR, Aldridge AP, Ronquest NA, Solem CT, Chilcoat H, Albright V, Johnson C, Learned SM, Mehra V, Heidbreder C. Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study. J Addict Med. 2020 Sep/Oct;14(5):e233-e240. doi: 10.1097/ADM.0000000000000647.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INDV-6000-N01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.